Glaxosmithkline Plc (GSK)

$40.62 0.35 (0.87%)

11:50 EDT GSK Stock Quote Delayed 15 Minutes

Volume:

Previous Close $40.27

Market Cap 100.73B

PE Ratio 97.64

EPS 0.416

Volume (Avg. Vol.) 1.08M

Day's Range 40.36 - 40.69

52-Week Range 36.41 - 42.32

Dividend & Yield 2.14 (5.27%)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc News

From InvestorPlace
From the Web

5 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor Jun 20, 2019

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

9 Blue-Chip Stocks That Will Lose You Money

By James Brumley, InvestorPlace Feature Writer Mar 5, 2019

Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.

3 Life Sciences Stocks to Invest In

By Chris Lau, InvestorPlace Contributor Mar 1, 2019

Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?

3 Biopharma Stocks to Buy for Their Robust Dividend Yields

By Tezcan Gecgil, InvestorPlace Contributor Jan 3, 2019

These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.

GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture

By William White, InvestorPlace Writer Dec 19, 2018

GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.

Compare Brokers

3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy

By James Brumley, InvestorPlace Feature Writer Dec 4, 2018

The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.

TSRO, GSK: Tesaro Stock Skyrockets on GlaxoSmithKline Deal

By William White, InvestorPlace Writer Dec 3, 2018

Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.

6 of the Best Dividend Stocks Outside the U.S.

By Vince Martin, InvestorPlace Contributor Oct 3, 2018

If you're looking for the best dividend stocks with high yields and solid growth prospects, don't limit yourself -- look overseas.

7 Healthcare Stocks That Are Coming to Life

By Anthony Mirhaydari, InvestorPlace Market Strategist Jul 23, 2018

These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.

GlaxoSmithKline Is More Than Just a 5% Dividend Income Play

By Chris Lau, InvestorPlace Contributor Jul 17, 2018

GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock.

7 Small-Cap Stocks to Consider for the Second Half of 2018

By James Brumley, InvestorPlace Feature Writer Jul 9, 2018

Small-cap stocks have been on a tear of late. Take the hint, and start your search with these seven top prospects.

Compare Brokers

The 3 Safest Dividend Stocks for International Exposure

By Lawrence Meyers, InvestorPlace Contributor Jul 5, 2018

International dividend stocks should make up a hefty portion of your portfolio, as you need them to smooth out the sort of stateside volatility we're experiencing right now.

4 Drug and Biotech Stocks Awaiting FDA Decisions in July

By Zacks Investment Research Jul 2, 2018

In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....

3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry

By Zacks Investment Research Jun 14, 2018

Though the large-cap pharma industry is struggling currently, there are a few stocks that are performing well. Compare Brokers....

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer May 18, 2018

The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.

GlaxoSmithKline plc Shares Sink on Q1 Earnings Miss

By William White, InvestorPlace Writer Apr 25, 2018

GlaxoSmithKline (GSK) stock was down on Wednesday following the release of an earnings report that misses estimates for the first quarter of 2018.

7 Dividend Stocks That May Be Hurting Your Retirement

By Brian Bollinger, Simply Safe Dividends Apr 25, 2018

Often there are signs leading up to dividend stocks cutting their payouts. If you own any of these 7 you'd be better off moving your money elsewhere.

Compare Brokers

Navellier Ratings

Total Grade

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Breaking news

Glaxosmithkline Plc (GSK)

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Breaking news

Glaxosmithkline Plc (GSK)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc News

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Subscriber Sign in